Described herein are pharmaceutical packaging methods which stop oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-sensitive medication, such devices which include a syringe having an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with pretty reduced permeability to ox